- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Mixed Tumor, Mullerian in Australia
Total 1064 results
-
Olivia Newton-John Cancer Research InstituteBristol-Myers SquibbActive, not recruitingGastrointestinal Cancer | Malignant Female Reproductive System Neoplasm | Neuroendocrine TumoursAustralia
-
David D'AndreaCompleted
-
National Cancer Institute (NCI)CompletedSarcoma | Lymphoma | Unspecified Childhood Solid Tumor, Protocol Specific | Brain and Central Nervous System Tumors | Neuroblastoma | RetinoblastomaUnited States, Canada, Puerto Rico, Australia, Netherlands, New Zealand, Switzerland
-
Novartis PharmaceuticalsCompletedCarcinoid Tumor | Malignant Carcinoid SyndromeFrance, Spain, Netherlands, United States, Canada, Sweden, Italy, Australia, Germany, Greece, Belgium, Czech Republic, Slovakia, Finland, United Kingdom
-
Hoffmann-La RocheCompletedMalignant MelanomaUnited States, Australia
-
Melanoma and Skin Cancer Trials LimitedMonash University; University of Sydney; The University of QueenslandActive, not recruitingMelanoma | Skin Cancer | Anxiety and FearAustralia
-
Syndax PharmaceuticalsRecruitingAcute Myeloid Leukemia | Acute Lymphoblastic Leukemia | Acute Leukemia of Ambiguous Lineage | Mixed Phenotype Acute Leukemia | Mixed Lineage Acute LeukemiaUnited States, Israel, Spain, Australia, Netherlands, Germany, Canada, France, Italy, Lithuania
-
European Organisation for Research and Treatment...UnknownTesticular Germ Cell Tumor | Teratoma | Extragonadal Germ Cell TumorFrance, Netherlands, Spain, United Kingdom, Norway, Belgium, Germany, Denmark, Hungary, Slovakia, Israel, Italy, Austria, Poland
-
European Organisation for Research and Treatment...CompletedTesticular Germ Cell Tumor | Ovarian Cancer | Extragonadal Germ Cell TumorFrance, Spain, Denmark, Netherlands, Norway, Belgium, United Kingdom, Israel, Italy, Switzerland, Germany, Portugal, Greece, Austria
-
New Approaches to Neuroblastoma Therapy ConsortiumNational Cancer Institute (NCI)Active, not recruitingNeuroblastomaCanada, United States, Australia
-
Nuvalent Inc.RecruitingMetastatic Solid Tumor | Locally Advanced Solid TumorUnited States, Australia, Taiwan, Spain, United Kingdom, France, Korea, Republic of, Canada, Singapore
-
National Cancer Institute (NCI)Active, not recruitingPRETEXT I Hepatoblastoma | PRETEXT II Hepatoblastoma | PRETEXT III Hepatoblastoma | PRETEXT IV HepatoblastomaUnited States, Canada, Puerto Rico, Australia, Japan, Brazil
-
Hoffmann-La RocheCompletedMelanomaUnited States, Italy, Australia, France, Spain, Netherlands
-
European Organisation for Research and Treatment...CompletedBrain and Central Nervous System TumorsNetherlands, Germany, Italy, France, Austria, Canada
-
IpsenTerminatedCarcinoid SyndromeSpain, Belgium, Ireland, Czechia, Israel, France, United Kingdom, Latvia, Germany, Russian Federation, Slovakia, Italy, Netherlands, Finland, Austria, Poland, Sweden, Ukraine
-
Merck Sharp & Dohme LLCTerminatedAdvanced/Metastatic MelanomaUnited States, Australia, Chile, France, Germany, Israel, Italy, Korea, Republic of, Norway, South Africa, Spain
-
MedImmune LLCCompletedRecurrent or Metastatic Solid TumorsUnited States, Australia
-
OncoSec Medical IncorporatedMerck Sharp & Dohme LLCActive, not recruitingStage III/IV MelanomaUnited States, Australia, Canada, Italy, Switzerland
-
Nationwide Children's HospitalNovartisNot yet recruitingGlioblastoma | Glioblastoma Multiforme | High Grade Glioma | Anaplastic Astrocytoma | Diffuse Intrinsic Pontine Glioma | Diffuse Midline Glioma, H3 K27M-Mutant | WHO Grade III Glioma | Metastatic Brain Tumor | WHO Grade IV GliomaUnited States, Australia, United Kingdom, Canada, Germany, Netherlands
-
Nationwide Children's HospitalNot yet recruitingGlioblastoma | Glioblastoma Multiforme | High Grade Glioma | Anaplastic Astrocytoma | Diffuse Intrinsic Pontine Glioma | Diffuse Midline Glioma, H3 K27M-Mutant | WHO Grade III Glioma | Metastatic Brain Tumor | WHO Grade IV GliomaUnited States, Australia, United Kingdom, Canada, Germany, Netherlands
-
Murdoch Childrens Research InstituteRoyal Children's Hospital; Peter MacCallum Cancer Centre, AustraliaNot yet recruitingArteriovenous Malformations | Vascular Malformations | MAP2K1 Gene Mutation | PIK3CA-related Overgrowth Spectrum | Vascular Anomalies | Lymphangioma | Lymphatic Malformation | KRAS G12D | Venous Malformation | Vascular Anomaly | KRAS G12C | PI3K Gene Mutation | Slow-Flow Vascular Malformation | Fast-Flow Vascular... and other conditionsAustralia
-
European Organisation for Research and Treatment...CompletedUnspecified Adult Solid Tumor, Protocol SpecificFrance, Norway, United Kingdom, Switzerland, Netherlands, Belgium, Austria, Denmark, Germany
-
GlaxoSmithKlineCompletedMelanomaFrance, Italy, Germany, Netherlands, Switzerland, United Kingdom, Austria, Australia
-
European Organisation for Research and Treatment...RecruitingMedulloblastomaFrance, Netherlands, Spain, Australia, Germany, Switzerland, Austria, Italy
-
Novartis PharmaceuticalsCompletedPancreatic Neoplasms | Neuroendocrine Tumor | Neuroendocrine Carcinoma | Islet Cell CarcinomaUnited States, Canada, Spain, Argentina, Germany, Belgium, Italy, France, Sweden, Australia, Netherlands
-
Gustave Roussy, Cancer Campus, Grand ParisNational Cancer Institute, FranceTerminatedVery High Risk NeuroblastomaItaly, Austria, France, Netherlands, Spain
-
Christoph ArnoldnerRecruiting
-
Medical University of ViennaRecruiting
-
Bristol-Myers SquibbCompletedPan TumorUnited States, Puerto Rico, Italy, Argentina, Australia, Belgium, Canada, Chile, Denmark, France, Germany, Netherlands, Poland, Romania, Singapore, Spain, United Kingdom
-
National Cancer Institute (NCI)Active, not recruitingGanglioneuroblastoma | High Risk NeuroblastomaUnited States, New Zealand, Australia
-
Arcispedale Santa Maria Nuova-IRCCSCompletedNeuroendocrine TumoursAustria, Italy
-
Turning Point Therapeutics, Inc.RecruitingLymphoma | Locally Advanced Solid Tumors | Metastatic Solid Tumors | Primary CNS TumorsUnited States, Korea, Republic of, Spain, Singapore, Taiwan, Australia, Italy, Canada, France, Denmark, United Kingdom
-
Genor Biopharma Co., Ltd.RecruitingNSCLC | Other Solid TumorsAustralia
-
Christoph ArnoldnerRecruitingHearing Loss | Vestibular SchwannomaAustria
-
Ascentage Pharma Group Inc.Merck Sharp & Dohme LLCRecruitingMelanoma | P53 Mutation | Uveal Melanoma | Cutaneous Melanoma | Mucosal Melanoma | Malignant Peripheral Nerve Sheath Tumors | MPNST | Unresectable or Metastatic Melanoma or Advanced Solid Tumors | MDM2 Gene MutationUnited States, Australia
-
Dragonfly TherapeuticsRecruitingSolid Tumor, AdultUnited States, Australia, France
-
CancerVax CorporationUnknownMelanoma (Skin)United States, Australia
-
PharmAbcineTerminatedRecurrent GlioblastomaAustralia, United States
-
European Organisation for Research and Treatment...SuspendedUnspecified Adult Solid Tumor, Protocol SpecificFrance, Netherlands, Norway, Belgium, Switzerland, Austria, United Kingdom, Germany, Denmark
-
European Organisation for Research and Treatment...WithdrawnUnspecified Adult Solid Tumor, Protocol SpecificFrance, Norway, Switzerland, Netherlands, Belgium, Austria, United Kingdom, Denmark, Germany
-
European Organisation for Research and Treatment...CompletedUnspecified Adult Solid Tumor, Protocol SpecificFrance, Netherlands, Norway, Belgium, Switzerland, Austria, United Kingdom, Germany, Denmark
-
Shanghai EpimAb Biotherapeutics Co., Ltd.TerminatedAdvanced Solid TumorsChina, Australia, United States
-
Children's Oncology GroupNational Cancer Institute (NCI); Pediatric Oncology GroupCompletedBrain Tumors | Central Nervous System TumorsUnited States, Puerto Rico, Switzerland, Australia, Canada
-
IpsenCompletedAcromegaly | Neuroendocrine TumoursSwitzerland, Austria, Germany
-
Children's Oncology GroupNational Cancer Institute (NCI); SWOG Cancer Research NetworkCompletedSarcomaUnited States, Canada, Australia, Switzerland, Puerto Rico, Netherlands, New Zealand
-
Children's Oncology GroupNational Cancer Institute (NCI)Active, not recruitingChildhood Central Nervous System Germinoma | Central Nervous System Nongerminomatous Germ Cell TumorUnited States, Canada, Puerto Rico, Australia, New Zealand
-
Genentech, Inc.Active, not recruitingMelanomaUnited States, Germany, Australia, Korea, Republic of, Canada, Norway
-
University of BirminghamRoche Pharma AG; Cancer Research UK; Imagine for Margo; EUSA Pharma, Inc.Active, not recruitingNeuroblastomaFrance, Austria, Belgium, Denmark, Ireland, Italy, Spain, Switzerland, United Kingdom, Netherlands
-
Hoffmann-La RocheCompletedSolid TumorsUnited States, Korea, Republic of, Australia, Canada, Germany, Singapore
-
University of BirminghamUniversity of Oslo; The Leeds Teaching Hospitals NHS Trust; University of Padova and other collaboratorsActive, not recruitingCarcinoma, Hepatocellular | HepatoblastomaUnited Kingdom, France, Austria, Israel, Spain, Belgium, Czechia, Finland, Germany, Ireland, Netherlands, Norway, Poland, Switzerland